United States · FDA National Drug Code directory
Marcaine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0409-0525_7040888c-2cde-4408-af99-d249985f8444
- Product NDC
- 0409-0525
- Form
- INJECTION, SOLUTION
- Composition / generic term
- BUPIVACAINE HYDROCHLORIDE
- Labeler
- Hospira, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20241209
- Source listing expiry
- 20271231
Source-listed ingredients
- BUPIVACAINE HYDROCHLORIDE — 250 mg/50mL
These values do not establish equivalence or a dose recommendation.
Packages
- 25 VIAL, MULTI-DOSE in 1 TRAY (0409-0525-25) / 50 mL in 1 VIAL, MULTI-DOSE (0409-0525-01) · 0409-0525-25
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →